ClinicalTrials.Veeva

Menu

Phase I Study of HAL Formulations Applied to the Cervix in Healthy Volunteers

P

Photocure

Status

Terminated

Conditions

Healthy

Study type

Observational

Funder types

Industry

Identifiers

NCT00496171
PC CE102/07

Details and patient eligibility

About

The purpose of the study is to determine the most effective formulation of HAL for release of hexaminolevulinate to the cervical epithelium at different doses.

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy, pre-menopausal female volunteers

Exclusion criteria

  • Acute or chronic disease which could influence the study results

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems